A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

March 31, 2007

Conditions
Fibromyalgia
Interventions
DRUG

Nabilone

Oral nabilone, 0.5 mg x7 days, increased to 0.5 mg t.i.d x 2 weeks if patient tolerates, then increase if patient tolerating to 0.5 in am and 1.0 mg at hs x 1 week, then if patient tolerating, increase to 1.0 mg b.i.d x 1 week.

Trial Locations (1)

R3A 1M4

Rehabilitation Hospital, Winnipeg

All Listed Sponsors
collaborator

Valeant Canada Limited

INDUSTRY

lead

Winnipeg Regional Health Authority

OTHER

NCT00272207 - A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia | Biotech Hunter | Biotech Hunter